South Korea
· Delayed Price · Currency is KRW CTCBIO Company Description
CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally.
The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products.
It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19.
In addition, the company offers coating base/plasticizer/pore former, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizer/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants.
CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.
| Country | South Korea |
| Founded | 1993 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 241 |
| CEO | Mingoo Lee |
Contact Details
Address: Tower A, 901 Hwaseong-si South Korea | |
| Phone | 82 1 661 8800 |
| Website | ctcbio.com |
Stock Details
| Ticker Symbol | 060590 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Mingoo Lee | Chief Executive Officer |